XKRX
161890
Market cap1.61bUSD
Jul 10, Last price
106,500.00KRW
1D
3.60%
1Q
34.98%
Jan 2017
61.85%
IPO
278.33%
Name
Kolmar Korea Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers skincare cosmetic products, including toners, lotions, ampoules, essences, creams, mask sheets, mask packs, and lip balms; fragrance products, such as perfumes, and cleansing products; body and hair products; and color cosmetic products comprising makeup bases, primers, foundation and concealers, cushion foundations, and mascaras. The company also provides powder base products, such as eye shadows, powder pacts, highlighters, blushers, shadings, loose powders, jelly powders, wet powders, multi-color concurrent forming, gradations, marble teracotas, hair cushions, essence powders, bubble salts, eyebrow pencils, highlighters, etc.; and oil & emulsification base products, including lip sticks, lip balms, lip glosses, tints, essence pacts, stick foundations, sun sticks, skin covers, gel eyeliners, marble essence pacts, core sticks, two-tone sticks, marble sticks, serum sticks, eye sticks, balms, concealers, etc. In addition, it offers PLATIT147, a health and beauty production platform. Further, the company engages in the real estate rental business and manufacturing of plastic molded containers. Kolmar Korea Co., Ltd. was founded in 1990 and is headquartered in Sejong City, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||